Clal Biotechnology Industries Ltd. (TLV:CBI)

TLV:CBI Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	48	55	62	98	185	319
Market Cap Growth	-12.09%	-12.09%	-36.78%	-46.87%	-41.79%	51.02%
Enterprise Value	74	91	109	144	336	496
Last Close Price	0.31	0.35	0.40	0.63	1.18	1.75
PE Ratio	-	-	-	-	-	2.92
PS Ratio	-	-	598.73	266.21	827.64	1546.13
PB Ratio	1.05	1.19	0.51	0.68	0.55	0.62
P/TBV Ratio	1.32	1.49	0.63	0.78	-	4.88
EV/Sales Ratio	-	-	1046.55	389.64	1498.60	2405.76
EV/EBITDA Ratio	-	-	-	28.06	34.03	37.47
Debt / Equity Ratio	0.45	0.45	0.30	0.25	0.16	0.10
Debt / EBITDA Ratio	-	-	-	7.15	5.45	3.84
Asset Turnover	-	-	0.00	0.00	0	0
Quick Ratio	0.25	0.25	2.01	4.65	1.70	6.95
Current Ratio	0.29	0.29	2.21	5.71	2.18	7.47
Return on Equity (ROE)	-89.60%	-89.60%	-21.10%	-16.98%	-15.63%	25.13%
Return on Assets (ROA)	-3.67%	-3.67%	-3.73%	-2.49%	-1.49%	-1.08%
Return on Capital (ROIC)	-3.70%	-3.70%	-3.76%	-2.72%	-1.65%	-1.18%
Earnings Yield	-128.87%	-114.10%	-49.87%	-62.68%	-48.32%	34.23%
FCF Yield	-	-11.83%	-13.68%	-61.23%	-23.15%	-11.43%
Dividend Yield	-	-	-	-	-	12.54%
Buyback Yield / Dilution	-1.02%	-1.02%	-	1.01%	1.74%	-0.01%
Total Shareholder Return	-1.02%	-1.02%	-	1.01%	1.74%	12.53%

Updated Aug 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.